Total Funding
48
1
Total FundingDebt Financing raised
Growth Score
-3 pts
Heat Score
-14 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
777466
NeurOp is a research company developing different drug compounds.
- Ray Dingledine: Co-founder, Board of Directors, SAB
Stephen F. Traynelis: Co-Founder
About the Company
NeurOp Corporation, a preclinical stage pharmaceutical company, engages in the development of disease activated small molecules for the treatment of central nervous system (CNS) diseases. It offers therapeutics for CNS indications, including ischemia, neuropathic pain, Parkinson's disease, and Alzheimer's disease. The company was
incorporated in 2002 and is based in Atlanta, Georgia.
